玻璃体切割术治疗视网膜静脉周围炎伴玻璃体出血

目的：评价玻璃体切割术治疗视网膜静脉周围炎伴玻璃体出血的疗效。方法：回顾性分析我院自1999年3月至2002年9月经玻璃体切割术治疗的视网膜静脉周围炎伴玻璃体出血患者13例18只眼的临床资料。结果：随访期为7个月～4年，平均23个月。18只眼视网膜均在位，16只眼(88.9％)视力较术前有不同程度的提高，其中视力≥0.3者11只眼(71％)，最好视力为1.0。术后玻璃体再出血2例，经药物治疗后出血吸收。无新生血管性青光眼发生。结论：玻璃体切割术是治疗视网膜静脉周围炎伴玻璃体出血的有效方法，可明显改善患者视力；结合术中及术后激光光凝治疗，可有效预防玻璃体再出血及新生血管性青光眼等并发症的发生。

Vitrectomy for Eales''''disease with vitreous hemorrhage

Objective:To evaluate the therapeutic effects of vitrectomy for Eales'disease with vitreous hemorrhage.Methods:The deta of 13 patients(18 eyes) of Eales'disease with vitreous hemorrhage who underwent vitrectomy from March,1999 to September,2002 were studied retrospectively.Results:The follow-up period was 1 year to 4 years(average,23 months).At the final examinations,the retinas were all attached,with improved visual acuity in 16 eyes(88.9%)of which 11 eyes(71%)reached 0.3 or better,the best visual acuity was 1.0.Recurrent vitreous hemorrhage occurred in only 2 eyes,and absorbed after drug therapy.No neovascular glaucoma occurred.Conclusion:Vitrectomy is an effective method for Eales'disease with vitreous hemorrhage.It can improve the visual acuity markedly.Combined with photocoagulation,it can also effectively prevent the recurrent vitreous hemorrhage and other complications.